Filing Details
- Accession Number:
- 0001596783-21-000189
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-03 15:35:03
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-11-03 15:35:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1596783 | Catalent Inc. | CTLT | Pharmaceutical Preparations (2834) | 208737688 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1721336 | Jonathan Arnold | C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 | Pres. Oral & Specialty Deliv. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-01 | 1,962 | $36.02 | 47,046 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-11-01 | 1,039 | $42.23 | 48,085 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-11-01 | 2,400 | $43.88 | 50,485 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-11-01 | 2,158 | $54.94 | 52,643 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-01 | 10,672 | $140.02 | 41,971 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase Common Stock | Disposition | 2021-11-01 | 1,962 | $0.00 | 1,962 | $36.02 |
| Common Stock | Options to purchase Common Stock | Disposition | 2021-11-01 | 1,039 | $0.00 | 1,039 | $42.23 |
| Common Stock | Options to purchase Common Stock | Disposition | 2021-11-01 | 2,400 | $0.00 | 2,400 | $43.88 |
| Common Stock | Options to purchase Common Stock | Disposition | 2021-11-01 | 2,158 | $0.00 | 2,158 | $54.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-07-24 | No | 4 | M | Direct | |
| 1,042 | 2027-10-04 | No | 4 | M | Direct | |
| 2,745 | 2028-07-23 | No | 4 | M | Direct | |
| 4,318 | 2029-07-22 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
- Includes restricted stock units.
- Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
- Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- On July 24, 2017, the reporting person was granted options to purchase 7,839 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on July 24, 2018.
- On October 4, 2017, the reporting person was granted options to purchase 4,159 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on October 4, 2018.
- The options vest and become exercisable in four equal annual installments beginning on July 23, 2019.
- The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.
Billionaire Hedge Funds
